Ge Li1,2, Eric B Larson3,4, Jane B Shofer1, Paul K Crane3, Laura E Gibbons3, Wayne McCormick3, James D Bowen5, Mary Lou Thompson6. 1. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington. 2. Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington. 3. Department of General Internal Medicine, University of Washington, Seattle, Washington. 4. Kaiser Permanente Washington Health Research Institute, Seattle, Washington. 5. Swedish Neuroscience Institute, Swedish Medical Center, Seattle, Washington. 6. Department of Biostatistics, University of Washington, Seattle, Washington.
Abstract
BACKGROUND/ OBJECTIVES: Longitudinal studies have shown an increase in cognitive decline many years before clinical diagnosis of dementia. We sought to estimate changes, relative to "normal" aging, in the trajectory of scores on a global cognitive function test-the Cognitive Abilities Screening Instrument (CASI). DESIGN: A prospective cohort study. SETTING: Community-dwelling members of a U.S. health maintenance organization. PARTICIPANTS: Individuals aged 65 and older who had no dementia diagnosis at baseline and had at least two visits with valid CASI test score (N = 4,315). MEASUREMENTS: Average longitudinal trajectories, including changes in trajectory before clinical diagnosis in those who would be diagnosed with dementia, were estimated for CASI item response theory (IRT) scores. The impact of sex, education level, and APOE genotype on cognitive trajectories was assessed. RESULTS: Increased cognitive decline relative to "normal" aging was evident in CASI IRT at least 10 years before clinical diagnosis. Male gender, lower education, and presence of ≥1 APOE ε4 alleles were associated with lower average IRT scores. In those who would be diagnosed with dementia, a trajectory change point was estimated at an average of 3.1 years (95% confidence interval 3.0-3.2) before clinical diagnosis, after which cognitive decline appeared to accelerate. The change point did not differ by sex, education level, or APOE ε4 genotype. There were subtle differences in trajectory slopes by sex and APOE ε4 genotype, but not by education. CONCLUSION: Decline in average global cognitive function was evident at least 10 years before clinical diagnosis of dementia. The decline accelerated about 3 years before clinical diagnosis.
BACKGROUND/ OBJECTIVES: Longitudinal studies have shown an increase in cognitive decline many years before clinical diagnosis of dementia. We sought to estimate changes, relative to "normal" aging, in the trajectory of scores on a global cognitive function test-the Cognitive Abilities Screening Instrument (CASI). DESIGN: A prospective cohort study. SETTING: Community-dwelling members of a U.S. health maintenance organization. PARTICIPANTS: Individuals aged 65 and older who had no dementia diagnosis at baseline and had at least two visits with valid CASI test score (N = 4,315). MEASUREMENTS: Average longitudinal trajectories, including changes in trajectory before clinical diagnosis in those who would be diagnosed with dementia, were estimated for CASI item response theory (IRT) scores. The impact of sex, education level, and APOE genotype on cognitive trajectories was assessed. RESULTS: Increased cognitive decline relative to "normal" aging was evident in CASI IRT at least 10 years before clinical diagnosis. Male gender, lower education, and presence of ≥1 APOE ε4 alleles were associated with lower average IRT scores. In those who would be diagnosed with dementia, a trajectory change point was estimated at an average of 3.1 years (95% confidence interval 3.0-3.2) before clinical diagnosis, after which cognitive decline appeared to accelerate. The change point did not differ by sex, education level, or APOE ε4 genotype. There were subtle differences in trajectory slopes by sex and APOE ε4 genotype, but not by education. CONCLUSION: Decline in average global cognitive function was evident at least 10 years before clinical diagnosis of dementia. The decline accelerated about 3 years before clinical diagnosis.
Authors: Lei Yu; Patricia Boyle; Robert S Wilson; Eisuke Segawa; Sue Leurgans; Philip L De Jager; David A Bennett Journal: Neuroepidemiology Date: 2012-07-17 Impact factor: 3.282
Authors: Daniel C Aguirre-Acevedo; Francisco Lopera; Eliana Henao; Victoria Tirado; Claudia Muñoz; Margarita Giraldo; Shrikant I Bangdiwala; Eric M Reiman; Pierre N Tariot; Jessica B Langbaum; Yakeel T Quiroz; Fabian Jaimes Journal: JAMA Neurol Date: 2016-04 Impact factor: 18.302
Authors: Andrea L C Schneider; A Richey Sharrett; Mehul D Patel; Alvaro Alonso; Josef Coresh; Thomas Mosley; Ola Selnes; Elizabeth Selvin; Rebecca F Gottesman Journal: J Am Geriatr Soc Date: 2012-09-26 Impact factor: 5.562
Authors: Ge Li; Kangping Xiong; Ane Korff; Catherine Pan; Joseph F Quinn; Douglas R Galasko; Chunfeng Liu; Thomas J Montine; Elaine R Peskind; Jing Zhang Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Hélène Amieva; Mélanie Le Goff; Xavier Millet; Jean Marc Orgogozo; Karine Pérès; Pascale Barberger-Gateau; Hélène Jacqmin-Gadda; Jean François Dartigues Journal: Ann Neurol Date: 2008-11 Impact factor: 10.422
Authors: Melinda C Power; Marc G Weisskopf; Stacey E Alexeeff; Brent A Coull; Avron Spiro; Joel Schwartz Journal: Environ Health Perspect Date: 2010-12-20 Impact factor: 9.031
Authors: Zimu Wu; Robyn L Woods; Trevor T J Chong; Suzanne G Orchard; Raj C Shah; Rory Wolfe; Elsdon Storey; Kerry M Sheets; Anne M Murray; John J McNeil; Joanne Ryan Journal: Front Med (Lausanne) Date: 2022-06-27
Authors: Andrea L Roberts; Jiaxuan Liu; Rebecca B Lawn; Shaili C Jha; Jennifer A Sumner; Jae H Kang; Eric B Rimm; Francine Grodstein; Laura D Kubzansky; Lori B Chibnik; Karestan C Koenen Journal: JAMA Netw Open Date: 2022-06-01
Authors: Aliza P Wingo; Thomas S Wingo; Wen Fan; Sharon Bergquist; Alvaro Alonso; Michele Marcus; Allan I Levey; James J Lah Journal: J Affect Disord Date: 2019-11-30 Impact factor: 4.839
Authors: Zachary A Marcum; Rod L Walker; Bobby L Jones; Arvind Ramaprasan; Shelly L Gray; Sascha Dublin; Paul K Crane; Eric B Larson Journal: BMC Geriatr Date: 2019-02-14 Impact factor: 3.921
Authors: Martin Lövdén; Laura Fratiglioni; M Maria Glymour; Ulman Lindenberger; Elliot M Tucker-Drob Journal: Psychol Sci Public Interest Date: 2020-08
Authors: Sander Lamballais; Ryan L Muetzel; Mohammad Arfan Ikram; Henning Tiemeier; Meike W Vernooij; Tonya White; Hieab H H Adams Journal: Front Psychiatry Date: 2020-02-07 Impact factor: 4.157